Systemic toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice

PLoS ONE

Volumn 5, Issue 7, 2010, Pages

  Aumeunier, Aude ^a,b   Grela, Françoise ^a,b   Ramadan, Abdulraouf ^a,b   Van, Linh Pham ^a,b   Bardel, Emilie ^a,b   Alcala, Alejandro Gomez ^a,b   Jeannin, Pascale ^c   Akira, Shizuo ^d   Bach, Jean François ^a,c   Thieblemont, Nathalie ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b CNRS   (France)

^c INSERM   (France)

^d OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; MYELOID DIFFERENTIATION FACTOR 88; PROBIOTIC AGENT; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; DOUBLE STRANDED RNA; IMIDAZOLE DERIVATIVE; LIPOPOLYSACCHARIDE; OMPA OUTER MEMBRANE PROTEINS; OUTER MEMBRANE PROTEIN; RESIQUIMOD; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; GENE ACTIVATION; GENETIC SUSCEPTIBILITY; IMMUNOREGULATION; MOUSE; MOUSE STRAIN; NATURAL KILLER T CELL; NONHUMAN; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; TH1 CELL; ANIMAL; ASTHMA; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; INSULIN DEPENDENT DIABETES MELLITUS; METABOLISM; NONOBESE DIABETIC MOUSE; PANCREAS; PATHOLOGY; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; ASTHMA; BACTERIAL OUTER MEMBRANE PROTEINS; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMIDAZOLES; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED NOD; MYELOID DIFFERENTIATION FACTOR 88; PANCREAS; PROBIOTICS; RNA, DOUBLE-STRANDED; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTORS;

EID: 77955369313     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011484     Document Type: Article

References (60)

1. Blander JM, Medzhitov R (2006) On regulation of phagosome maturation and antigen presentation. Nat Immunol 7: 1029-1035.
2. Kumar H, Kawai T, Akira S (2009) Pathogen recognition in the innate immune response. Biochem J 420: 1-16.
3. Beutler B (2009) Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunological Reviews 227: 248-263.
4. Anders HJ, Vielhauer V, Eis V, Linde Y, Kretzler M, et al. (2004) Activation of toll-like receptor-9 induces progression of renal disease in MRL-Fas(lpr) mice. Faseb J 18: 534-536.
5. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, et al. (2005) Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease. Nat Med 11: 138-145.
6. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
7. Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, et al. (2005) RNA-associated autoantigens activate B cells by combined B cell antigen receptor/ Toll-like receptor 7 engagement. J Exp Med 202: 1171-1177.
8. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, et al. (2009) House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nature Medicine 15: 410-416.
9. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, et al. (2009) Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457: 585-588.
10. Marty RR, Dirnhofer S, Mauermann N, Schweikert S, Akira S, et al. (2006) MyD88 signaling controls autoimmune myocarditis induction. Circulation 113: 258-265.
11. Su SB, Silver PB, Grajewski RS, Agarwal RK, TangJ, et al. (2005) Essential role of the MyD88 pathway, but nonessential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J Immunol 175: 6303-6310.
12. Serreze DV, Hamaguchi K, Leiter EH (1989) Immunostimulation circumvents diabetes in NOD/Lt mice. J Autoimmun 2: 759-776.
13. Quintana FJ, Rotem A, Carmi P, Cohen IR (2000) Vaccination with empty plasmid DNA or CpG oligonucleotide inhibits diabetes in nonobese diabetic mice: modulation of spontaneous 60-kDa heat shock protein autoimmunity. J Immunol 165: 6148-6155.
14. Sel S, Wegmann M, Bauer S, Garn H, Alber G, et al. (2007) Immunomod-ulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol 178: 7805-7813.
15. Akdis CA, Kussebi F, Pulendran B, Akdis M, Lauener RP, et al. (2003) Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur J Immunol 33: 2717-2726.
16. Camateros P, Tamaoka M, Hassan M, Marino R, Moisan J, et al. (2007) Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am J Respir Crit Care Med 175: 1241-1249.
17. Patel M, Xu D, Kewin P, Choo-Kang B, McSharry C, et al. (2005) TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J Immunol 174: 7558-7563.
18. Moisan J, Camateros P, Thuraisingam T, Marion D, Koohsari H, et al. (2006) TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am J Physiol Lung Cell Mol Physiol 290: L987-995.
19. Tulic MK, Hurrelbrink RJ, Prele CM, Laing IA, UphamJW, et al. (2007) TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. Journal of Immunology 179: 132-140.
20. Hollingsworth JW, Whitehead GS, Lin KL, Nakano H, Gunn MD, et al. (2006) TLR4 signaling attenuates ongoing allergic inflammation. Journal of Immunology 176: 5856-5862.
21. Jeon SG, Oh SY, Park HK, Kim YS, Shim EJ, et al. (2007) TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses ofdouble-stranded RNA. J Allergy Clin Immunol 120: 803-812.
22. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, et al. (2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172: 2739-2743.
23. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, et al. (2002) Lipopolysaccharide-enhanced, toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 196: 1645-1651.
24. Murakami D, Yamada H, Yajima T, Masuda A, Komune S, et al. (2007) Lipopolysaccharide inhalation exacerbates allergic airway inflammation by activating mast cells and promoting Th2 responses. Clin Exp Allergy 37: 339-347.
25. Shah U, Walker WA (2002) Pathophysiology of intestinal food allergy. Adv Pediatr 49: 299-316.
26. Strachan DP (1989) Hay fever, hygiene, and household size. Bmj 299: 1259-1260.
27. Conrad ML, Ferstl R, Teich R, Brand S, Blumer N, et al. (2009) Maternal TLR signaling is required for prenatal asthma protection by the nonpathogenic microbe Acinetobacter lwoffii F78. Journal of Experimental Medicine 206: 2869-2877.
28. Bach JF (2002) The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 347: 911-920.
29. Sadelain MW, Qin HY, Lauzon J, Singh B (1990) Prevention of type I diabetes in NOD mice by adjuvant immunotherapy. Diabetes 39: 583-589.
30. Zaccone P, Raine T, Sidobre S, Kronenberg M, Mastroeni P, et al. (2004) Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice. Eur J Immunol 34: 3246-3256.
31. Alyanakian MA, Grela F, Aumeunier A, Chiavaroli C, Gouarin C, et al. (2006) Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes 55: 179-185.
32. Takei I, Asaba Y, Kasatani T, Maruyama T, Watanabe K, et al. (1992) Suppression of development ofdiabetes in NOD mice by lactate dehydrogenase virus infection. J Autoimmun 5: 665-673.
33. Bach JF (1994) Insulin-dependent diabetes mellitus as an autoimmune disease. Endocrine Rev 15: 516-542.
34. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, et al. (1980) Breeding of a non-obese, diabetic strain of mice. Exp Anim 29: 1-13.
35. Araujo LM, Lefort J, Nahori MA, Diem S, Zhu R, et al. (2004) Exacerbated Th2-mediated airway inflammation and hyperresponsiveness in autoimmune diabetes-prone NOD mice: a critical role for CD1d-dependent NKT cells. European Journal of Immunology 34: 327-335.
36. Wen L, Ley RE, Volchkov PY, Stranges PB, Avanesyan L, et al. (2008) Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 455: 1109-1113.
37. Jeannin P, Bottazzi B, Sironi M, Doni A, Rusnati M, et al. (2005) Complexity and complementarity ofouter membrane protein A recognition by cellular and humoral innate immunity receptors. Immunity 22: 551-560.
38. Tarkowski M, Vanoirbeek JA, Vanhooren HM, De Vooght V, Mercier CM, et al. (2007) Immunological determinants ofventilatory changes induced in mice by dermal sensitization and respiratory challenge with toluene diisocyanate. Am JPhysiol Lung Cell Mol Physiol 292: L207-214.
39. O'Neill LA, Bowie AG (2007) The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 7: 353-364.
40. Schnare M, Barton GM, Holt AC, Takeda K, Akira S, et al. (2001) Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2: 947-950.
41. Okada H, Kuhn C, Feillet H, Bach JF (2010) The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clinical and Experimental Immunology 160: 1-9.
42. Lenschow DJ, Herold KC, Rhee L, Patel B, Koons A, et al. (1996) CD28/B7 regulation ofTh1 and Th2 subsets in the development ofautoimmune diabetes. Immunity 5: 285-293.
43. Kimzey SL, Liu P, Green JM (2004) Requirement for CD28 in the effector phase of allergic airway inflammation. Journal of Immunology 173: 632-640.
44. Salomon B, Lenschow DJ, Rhee L, Ashourian N, Singh B, et al. (2000) B7/CD28 Costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 12: 431-440.
45. Mendiratta SK, Martin WD, Hong S, Boesteanu A, Joyce S, et al. (1997) CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity 6: 469-477.
46. _ /-) mice. Journal of Immunology 184: 212-221.
47. Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, et al. (2001) Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet 357: 1076-1079.
48. Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E (2003) Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 361: 1869-1871.
49. Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, et al. (2003) Effect ofprobiotic Lactobacillus strains in children with atopic dermatitis.J Allergy Clin Immunol 111: 389-395.
50. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609.
51. Nyirenda MH, O'Brien K, Sanvito L, Constantinescu CS, Gran B (2009) Modulation ofregulatory T cells in health and disease: role oftoll-like receptors. Inflamm Allergy Drug Targets 8: 124-129.
52. Caramalho I, Lopes-Carvalho T, Ostler D, Zelenay S, Haury M, et al. (2003) Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J Exp Med 197: 403-411.
53. Pasare C, Medzhitov R (2003) Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
54. Liu H, Komai-Koma M, Xu D, Liew FY (2006) Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci U S A 103: 7048-7053.
55. Yanaba K, Bouaziz JD, Haas KM, Poe JC, Fujimoto M, et al. (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28: 639-650.
56. Bouaziz JD, Yanaba K, Tedder TF (2008) Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 224: 201-214.
57. Fillatreau S, Sweenie CH, McGeachy MJ, Gray D, Anderton SM (2002) B cells regulate autoimmunity by provision of IL-10. Nat Immunol 3: 944-950.
58. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, et al. (2001) Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 167: 1081-1089.
59. Skyler J (2002) Effects of insulin in relatives of patients with type 1 diabetes mellitus Diabetes Prevention Trial-Type 1 Diabetes Study Group. N Engl J Med 346: 1685-1691.
60. Nanto-Salonen K, Kupila A, Simell S, Siljander H, Salonsaari T, et al. (2008) Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomized controlled trial. Lancet 372: 1746-1755.